Bulgaria – Pharmaceutical products – Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health
Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry o
Opportunity description
Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health. The Contractor agrees, after receiving a letter of consent from the Bulgarian Drug Agency (BDA) and a written request for delivery of the medicinal product specified below, to deliver the following medicinal product in the quantities prescribed by “UMHAT St. Ivan Rilski” EAD by protocol – Annex No. 1 (which is applicable), issued in accordance with Ordinance No. 10/17.11.2011, as per the CONTRACTOR'S offer. - International nonproprietary name: Anakinra, Kineret, Swedish Prphan Biovitrum AB, 100 mg / 0.67 ml solution for injection in pre-filled syringe-PFS, number of dosage forms per package 7, quantity of packages -12; Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.